MARKET

FHTX

FHTX

Foghorn Therapeutics Inc.
NASDAQ
3.870
+0.160
+4.31%
After Hours: 3.830 -0.04 -1.03% 18:05 06/09 EDT
OPEN
3.750
PREV CLOSE
3.710
HIGH
3.880
LOW
3.720
VOLUME
138.20K
TURNOVER
--
52 WEEK HIGH
6.95
52 WEEK LOW
3.270
MARKET CAP
227.22M
P/E (TTM)
-3.3202
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at FHTX last week (0601-0605)?
Weekly Report · 1d ago
Foghorn Therapeutics to present at Goldman Sachs Global Healthcare Conference 2026
PUBT · 4d ago
Foghorn Therapeutics to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference 2026
Barchart · 4d ago
Analysts Offer Insights on Healthcare Companies: Foghorn Therapeutics (FHTX) and Jade Biosciences (JBIO)
TipRanks · 06/01 15:50
Weekly Report: what happened at FHTX last week (0525-0529)?
Weekly Report · 06/01 09:43
Weekly Report: what happened at FHTX last week (0518-0522)?
Weekly Report · 05/25 09:45
Weekly Report: what happened at FHTX last week (0511-0515)?
Weekly Report · 05/18 09:44
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga · 05/15 21:06
More
About FHTX
Foghorn Therapeutics Inc. is a clinical-stage, precision therapeutics biotechnology company. The Company is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control platform, it is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The Company is also developing multiple product candidates in oncology. The Gene Traffic Control platform provides an integrated and mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing to identify, validate and potentially drug targets within this system. Its platform enables to produce components of the chromatin regulatory system at scale, thereby allowing to identify these genetic dependencies, understand their mechanism and target their vulnerabilities.

Webull offers Foghorn Therapeutics Inc stock information, including NASDAQ: FHTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, FHTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading FHTX stock methods without spending real money on the virtual paper trading platform.